Empowered Patient Podcast

Welcome to the Empowered Patient Podcast with Karen Jagoda. This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape. Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes Value-based healthcare Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Using Neuroimaging and Deep Brain Stimulation to Provide Durable Relief for Severe Treatment-Resistant Depression with Dr. Mark George TRANSCEND Study TRANSCRIPT

Download PDF

Aug 25, 2026

Dr. Mark George is the principal psychiatric investigator of Abbott's TRANSCEND study and also a professor of psychiatry at MUSC Health Institute of Psychiatry. The TRANSCEND study represents a paradigm shift in depression treatment by investigating deep brain stimulation as a potential solution...

Using Neuroimaging and Deep Brain Stimulation to Provide Durable Relief for Severe Treatment-Resistant Depression with Dr. Mark George TRANSCEND Study

Aug 25, 2026

Psychedelic Medicine Effectively Treats PTSD and Depression with Dane Stevens Optimi Health TRANSCRIPT

Download PDF

Mar 18, 2026

Dane Stevens, Founder, CEO, and Director at Optimi Health, a Canadian company that manufactures MDMA and naturally derived psilocybin from mushrooms for use in therapy for PTSD and treatment-resistant depression. These psychedelic-based mental health treatments are being used in the regulated market in Australia and in...

Psychedelic Medicine Effectively Treats PTSD and Depression with Dane Stevens Optimi Health

Mar 18, 2026

Developing Psychedelic Therapy for Rapid Improvement of Postpartum Depression with Greg Mayes Reunion Neuroscience TRANSCRIPT

Download PDF

Dec 17, 2024

Greg Mayes, President and CEO of Reunion Neuroscience, is developing a psychedelic therapy for the treatment of postpartum depression. This serious acute, non-chronic mental health condition affects an estimated 20% of women after giving birth. A phase two trial is underway to evaluate how RE-104, a rapid-acting...